Published in J Infect Dis on November 01, 1980
Antigenic specificities of human CD4+ T-cell clones recovered from recurrent genital herpes simplex virus type 2 lesions. J Virol (1994) 1.83
Expression of cutaneous lymphocyte-associated antigen by CD8(+) T cells specific for a skin-tropic virus. J Clin Invest (2002) 1.79
Immunodominance among herpes simplex virus-specific CD8 T cells expressing a tissue-specific homing receptor. Proc Natl Acad Sci U S A (2003) 1.36
Herpes simplex virus infection of human fibroblasts and keratinocytes inhibits recognition by cloned CD8+ cytotoxic T lymphocytes. J Clin Invest (1993) 1.31
Cross-presentation and genome-wide screening reveal candidate T cells antigens for a herpes simplex virus type 1 vaccine. J Clin Invest (2012) 1.16
Recognition of herpes simplex virus type 2 tegument proteins by CD4 T cells infiltrating human genital herpes lesions. J Virol (1998) 1.11
CD4 T-cell responses to herpes simplex virus type 2 major capsid protein VP5: comparison with responses to tegument and envelope glycoproteins. J Virol (2000) 0.92
The natural history of recurrent herpes simplex labialis: implications for antiviral therapy. N Engl J Med (1977) 3.61
The course of untreated recurrent genital herpes simplex infection in 27 women. N Engl J Med (1981) 1.89
Clinical efficacy of high-dose acyclovir in patients with human immunodeficiency virus infection: a meta-analysis of randomized individual patient data. J Infect Dis (1998) 1.88
Treatment of herpes simplex labialis with topical acyclovir in polyethylene glycol. J Infect Dis (1982) 1.72
Comparison of new topical treatments for herpes labialis: efficacy of penciclovir cream, acyclovir cream, and n-docosanol cream against experimental cutaneous herpes simplex virus type 1 infection. Arch Dermatol (2001) 1.54
Prospects for control of herpes simplex virus disease through immunization. Clin Infect Dis (2000) 1.51
A randomized, placebo-controlled comparison of oral valacyclovir and acyclovir in immunocompetent patients with recurrent genital herpes infections. The Valaciclovir International Study Group. Arch Dermatol (1998) 1.39
Penetration of guinea pig skin by acyclovir in different vehicles and correlation with the efficacy of topical therapy of experimental cutaneous herpes simplex virus infection. Antimicrob Agents Chemother (1984) 1.37
Treatment of genital warts with an immune-response modifier (imiquimod). J Am Acad Dermatol (1998) 1.32
Early, patient-initiated treatment of herpes labialis with topical 10% acyclovir. Antimicrob Agents Chemother (1984) 1.12
Pathogenesis of recurrent herpes simplex labialis. IV. Maturation of lesions within 8 hours after onset and implications for antiviral treatment. Oral Surg Oral Med Oral Pathol (1984) 1.12
Failure of topical acyclovir in ointment to penetrate human skin. Antimicrob Agents Chemother (1986) 1.09
Pathogenesis of herpes simplex labialis: excretion of virus in the oral cavity. J Clin Microbiol (1984) 1.08
Clinical and virologic course of herpes simplex genitalis. West J Med (1979) 1.07
Chronic arthropathy associated with rubella vaccination. Arthritis Rheum (1977) 1.07
Ineffectiveness of topical adenine arabinoside 5'-monophosphate in the treatment of recurrent herpes simplex labialis. N Engl J Med (1979) 1.07
Typing of herpes simplex virus with type-specific human immunoglobulin M in an indirect immunofluorescence assay. J Clin Microbiol (1982) 1.05
Viral-induced leukocyte interferon in vesicle fluid from lesions of recurrent herpes labialis. J Infect Dis (1981) 1.03
Anti-interleukin-6 antibodies inhibit herpes simplex virus reactivation. J Infect Dis (1997) 1.02
Joint complications associated with derivatives of HPV-77 rubella virus vaccine. Am J Dis Child (1971) 1.02
The presence of a dehydroepiandrosterone-specific receptor binding complex in murine T cells. J Steroid Biochem Mol Biol (1992) 1.00
Post-herpetic erythema multiforme prevented with prophylactic oral acyclovir. Ann Intern Med (1985) 0.96
Pathogenesis of herpes simplex labialis: experimental induction of lesions with UV light. J Clin Microbiol (1985) 0.96
The histopathologic evolution of recurrent herpes simplex labialis. J Am Acad Dermatol (1981) 0.95
Efficacy of topical treatment for herpes simplex virus infections: predictions from an index of drug characteristics in vitro. J Infect Dis (1986) 0.93
Neuronal reactivation of herpes simplex virus may involve interleukin-6. J Neurovirol (1997) 0.93
Pharmacokinetics and pharmacodynamics of a humanized monoclonal antibody to factor IX in cynomolgus monkeys. J Pharmacol Exp Ther (2000) 0.92
Pathogenesis of herpes simplex labialis: correlation of vesicle fluid interferon with lesion age and virus titer. Infect Immun (1982) 0.91
Preclinical assessment of topical treatments of herpes simplex virus infection: 5% (E)-5-(2-bromovinyl)-2'-deoxyuridine cream. Antiviral Res (1985) 0.90
Latent period of 53 years in a case of hydatid cyst disease. Arch Intern Med (1974) 0.89
Growth of Newcastle disease virus and rubella virus in rheumatoid and nonrehumatoid synovial cell cultures. Infect Immun (1972) 0.89
Topical 5 percent acyclovir in polyethylene glycol for herpes simplex labialis. Antiviral effect without clinical benefit. Am J Med (1982) 0.88
Ofloxacin versus doxycycline for treatment of cervical infection with Chlamydia trachomatis. Antimicrob Agents Chemother (1992) 0.88
Recombinant human interferon-alpha A treatment of an experimental cutaneous herpes simplex virus type 1 infection of guinea pigs. J Interferon Res (1987) 0.88
Chronic meningitis caused by Propionibacterium acnes. A potentially important clinical entity. Neurology (1974) 0.88
Nucleic acid vaccine encoding gD2 protects mice from herpes simplex virus type 2 disease. J Infect Dis (1996) 0.88
Effect of azone and propylene glycol on penetration of trifluorothymidine through skin and efficacy of different topical formulations against cutaneous herpes simplex virus infections in guinea pigs. Antimicrob Agents Chemother (1984) 0.86
Double-blind, randomized, placebo-controlled study of topical 5% acyclovir-1% hydrocortisone cream (ME-609) for treatment of UV radiation-induced herpes labialis. Antimicrob Agents Chemother (2002) 0.86
Value of open-lung biopsy in 87 immunocompromised patients with pulmonary infiltrates. Cancer (1985) 0.86
Correlation between detection of herpes simplex virus in oral secretions by PCR and susceptibility to experimental UV radiation-induced herpes labialis. J Clin Microbiol (1994) 0.86
Inhibition of phytohaemagglutinin-induced lymphocyte proliferation by immunosuppressive drugs: use of whole blood culture. Immunopharmacol Immunotoxicol (1994) 0.85
Signal transducers and activators of transcription (Stat) are detectable in mouse trigeminal ganglion neurons. J Interferon Cytokine Res (2001) 0.84
Treatment of recurrent herpes simplex labialis with levamisole. Antimicrob Agents Chemother (1979) 0.83
Effect of foscarnet cream on experimental UV radiation-induced herpes labialis. Antimicrob Agents Chemother (1997) 0.83
Multiple sclerosis attacks are associated with picornavirus infections. Mult Scler (2004) 0.82
Rocky Mountain spotted fever following cardiac transplantation. West J Med (1993) 0.82
Recurrent joint symptoms in children vaccinated with HPV-77DK12 rubella vaccine. J Pediatr (1972) 0.82
Comparison of topically applied 5-ethyl-2'-deoxyuridine and acyclovir in the treatment of cutaneous herpes simplex virus infection in guinea pigs. Antimicrob Agents Chemother (1985) 0.82
Favorable outcome of central nervous system toxoplasmosis occurring in a patient with untreated Hodgkin's disease. Cancer (1980) 0.82
DNA polymerase activity of cultured rheumatoid synovial cells. Arthritis Rheum (1975) 0.81
Topical ether and herpes simplex labialis. JAMA (1980) 0.81
Colorado Tick Fever. A review of 115 laboratory confirmed cases. Arch Intern Med (1973) 0.81
STAT1 binds to the herpes simplex virus type 1 latency-associated transcript promoter. J Neurovirol (2004) 0.80
HLA and recurrent episodic arthropathy associated with rubella vaccination. Arthritis Rheum (1977) 0.79
Comparison of foscarnet cream, acyclovir cream, and acyclovir ointment in the topical treatment of experimental cutaneous herpes simplex virus type 1 infection. Antimicrob Agents Chemother (1986) 0.79
Disposition of tacrolimus (FK 506) in rabbits. Role of red blood cell binding in hepatic clearance. Drug Metab Dispos (1993) 0.79
Herpes labialis associated with recombinant human ciliary neurotrophic factor. J Infect Dis (1994) 0.79
Immune-specific interferon production by peripheral blood mononuclear leukocytes from patients with primary and recurrent oro-labial herpes simplex virus infections. J Med Virol (1985) 0.78
Treatment of acyclovir-unresponsive cutaneous herpes simplex virus infection with topically applied SP-303. Antiviral Res (1994) 0.78
Value of serum arabinitol for the management of Candida infections in clinical practice. Mycopathologia (1986) 0.78
Tolerance and percutaneous absorption of topically applied arildone. J Clin Pharmacol (1985) 0.78
Preparation and characterization of high-specific activity radiolabeled 50 S measles virus RNA. J Virol Methods (1980) 0.77
Pharmacokinetic and pharmacodynamic effects of coadministration of methylprednisolone and tacrolimus in rabbits. J Pharmacol Exp Ther (1994) 0.77
Simultaneous cytomegalovirus and herpes simplex virus pneumonia. Arch Pathol Lab Med (1987) 0.77
Dimethyl sulfoxide as a vehicle for topical antiviral chemotherapy. Ann N Y Acad Sci (1983) 0.76
Lack of ocular changes with dimethyl sulfoxide therapy of scleroderma. Pharmacotherapy (1989) 0.76
Measurement of the stratum corneum drug reservoir to predict the therapeutic efficacy of topical iododeoxyuridine for herpes simplex virus infection. J Invest Dermatol (1987) 0.75
A placebo-controlled trial of topical 8% arildone cream early in recurrent genital herpes. Antimicrob Agents Chemother (1986) 0.75
Successful medical treatment of listerial brain abscess. West J Med (1990) 0.75
A clinical and serological study of women exposed to rubella vaccinees. Am J Dis Child (1972) 0.75
Detection of asymptomatic hydatid disease by a community screening program. Am J Epidemiol (1973) 0.75
DNA synthesis and DNA polymerase activity in Leydig cells of diethylstilbestrol-stimulated mouse testes. Cancer Res (1978) 0.75
Treatment of recurrent herpes simplex labialis with topical butylated hydroxytoluene. Clin Pharmacol Ther (1985) 0.75
Immunostimulatory function of herpes simplex virus isolates from patients with frequent herpes labialis and a deficiency in immune-specific interferon production. J Med Virol (1985) 0.75
Spontaneous and induced interferon production by peripheral blood mononuclear leukocytes from humans with herpes labialis. J Immunol (1983) 0.75
Bell palsy and herpes simplex virus. Ann Intern Med (1994) 0.75
Induced regional differences in cutaneous cell-mediated immunity in the mouse. Int Arch Allergy Appl Immunol (1986) 0.75
Endemic hydatid disease in Utah. A review. Rocky Mt Med J (1974) 0.75